Back
Acadia Realty Trust 10K Form
Buy
60
AKR
Acadia Realty Trust
Last Price:
$19.60
Seasonality Move:
2.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | AKR/Acadia Realty Trust Quarterly |
2024-02-16 | 10K | AKR/Acadia Realty Trust Annual |
2023-10-31 | 10Q | AKR/Acadia Realty Trust Quarterly |
2023-08-02 | 10Q | AKR/Acadia Realty Trust Quarterly |
2023-05-05 | 10Q | AKR/Acadia Realty Trust Quarterly |
2023-03-01 | 10K | AKR/Acadia Realty Trust Annual |
Receive AKR News And Ratings
See the #1 stock for the next 7 days that we like better than AKR
AKR Financial Statistics
Sales & Book Value
Annual Sales: | $359.7M |
---|---|
Cash Flow: | $37.9M |
Price / Cash Flow: | 15.11 |
Annual Sales: | $17.26 |
Price / Book: | 1.14 |
Profitability
EPS (TTM): | 0.18000 |
---|---|
Net Income (TTM): | $21.7M |
Gross Margin: | $247.6M |
Return on Equity: | 0.93% |
Return on Assets: | 0.5% |
Acadia Realty Trust Earnings Forecast
Key Acadia Realty Trust Financial Ratios
-
The Gross Profit Margin over the past 18 years for AKR is 68.85%.
-
The Selling, General & Administrative Expenses for AKR have been equal to 11.28% of Gross Profit Margin.
-
The Interest Expense is 427.52% of Operating Income.
-
The Net Earning history of AKR is 6.02% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 11 years.
Acadia Realty Trust Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Retail REITs |
Sector: | Real Estate |
Current Symbol: | AKR |
CUSIP: | 004239 |
Website: | acadiarealty.com |
Debt
Debt-to-Equity Ratio: | 0.74 |
---|---|
Current Ratio: | 1.87 |
Quick Ratio: | 1.57 |
Price-to-Earnings
Trailing P/E Ratio: | 103.16 |
---|---|
Forward P/E Ratio: | 59.39 |
AKR Technical Analysis vs Fundamental Analysis
Buy
60
Acadia Realty Trust (AKR)
is a Buy
Is Acadia Realty Trust a Buy or a Sell?
-
Acadia Realty Trust stock is rated a BuyThe current Acadia Realty Trust [AKR] share price is $19.60. The Score for AKR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.